Researchers have identified blood-based biomarkers associated with both delirium duration and severity in critically ill patients. This finding opens the door to easy, early identification of individuals at risk for longer delirium duration and higher delirium severity and could potentially lead to new treatments of this brain failure for which drugs have been shown to be largely ineffective.
from Latest Science News -- ScienceDaily https://ift.tt/2GaOoWz
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment